Ono Pharmaceutical announces board and officer changes

Osaka, Japan – Ono Pharmaceutical Co., Ltd. (TSE:4528) announced planned changes to its Board of Directors and Corporate Officers following a meeting held today. The appointments are slated for finalization at the 77th Annual Shareholders Meeting in June 2025. All six incumbent board members will be re-appointed. Key corporate officer changes include the promotion of Masaki Ito to Corporate Executive Officer, where he will oversee Corporate Strategy & Planning, Business Management, and serve as President of Ono Digital health Investment, GK. Additionally, Satoshi Takahagi will take on a new role, and Hitoshi Mito is a new candidate for Corporate Officer, serving as Executive Director of Digital Technology. The full slate of directors, supervisory board members and executive officers is listed in the announcement.